227 related articles for article (PubMed ID: 17008123)
1. Herd protection against influenza.
Glezen WP
J Clin Virol; 2006 Dec; 37(4):237-43. PubMed ID: 17008123
[TBL] [Abstract][Full Text] [Related]
2. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.
Piedra PA; Gaglani MJ; Kozinetz CA; Herschler GB; Fewlass C; Harvey D; Zimmerman N; Glezen WP
Pediatrics; 2007 Sep; 120(3):e553-64. PubMed ID: 17698577
[TBL] [Abstract][Full Text] [Related]
3. Universal influenza vaccination and live attenuated influenza vaccination of children.
Glezen WP
Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S104-9. PubMed ID: 18820568
[TBL] [Abstract][Full Text] [Related]
4. Safety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children.
Belshe RB; Gruber WC
Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1947-51. PubMed ID: 11779396
[TBL] [Abstract][Full Text] [Related]
5. Live attenuated influenza vaccine in children.
Ambrose CS; Walker RE; Connor EM
Semin Pediatr Infect Dis; 2006 Oct; 17(4):206-12. PubMed ID: 17055372
[TBL] [Abstract][Full Text] [Related]
6. Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine.
Belshe R; Lee MS; Walker RE; Stoddard J; Mendelman PM
Expert Rev Vaccines; 2004 Dec; 3(6):643-54. PubMed ID: 15606348
[TBL] [Abstract][Full Text] [Related]
7. Optimizing protection against influenza in children eligible for the vaccine for children program.
Hull HF; O'Connor H
Pediatr Infect Dis J; 2010 Oct; 29(10):910-4. PubMed ID: 20431426
[TBL] [Abstract][Full Text] [Related]
8. Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children.
Piedra PA; Gaglani MJ; Kozinetz CA; Herschler G; Riggs M; Griffith M; Fewlass C; Watts M; Hessel C; Cordova J; Glezen WP
Vaccine; 2005 Feb; 23(13):1540-8. PubMed ID: 15694506
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children.
Bracco Neto H; Farhat CK; Tregnaghi MW; Madhi SA; Razmpour A; Palladino G; Small MG; Gruber WC; Forrest BD;
Pediatr Infect Dis J; 2009 May; 28(5):365-71. PubMed ID: 19395948
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.
Luce BR; Nichol KL; Belshe RB; Frick KD; Li SX; Boscoe A; Rousculp MD; Mahadevia PJ
Vaccine; 2008 Jun; 26(23):2841-8. PubMed ID: 18462851
[TBL] [Abstract][Full Text] [Related]
11. Asthma, influenza, and vaccination.
Glezen WP
J Allergy Clin Immunol; 2006 Dec; 118(6):1199-206; quiz 1207-8. PubMed ID: 17157648
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of live attenuated influenza vaccine in children 2-7 years of age.
Belshe RB; Ambrose CS; Yi T
Vaccine; 2008 Sep; 26 Suppl 4():D10-6. PubMed ID: 18611422
[TBL] [Abstract][Full Text] [Related]
13. Update on universal annual influenza immunization recommendations for children.
Bekker A; Chou C; Bernstein HH
Curr Opin Pediatr; 2009 Feb; 21(1):122-6. PubMed ID: 19242248
[TBL] [Abstract][Full Text] [Related]
14. Cold-adapted, live attenuated influenza vaccine.
Glezen WP
Expert Rev Vaccines; 2004 Apr; 3(2):131-9. PubMed ID: 15056039
[TBL] [Abstract][Full Text] [Related]
15. A multinational, randomized, placebo-controlled trial to assess the immunogenicity, safety, and tolerability of live attenuated influenza vaccine coadministered with oral poliovirus vaccine in healthy young children.
Breiman RF; Brooks WA; Goswami D; Lagos R; Borja-Tabora C; Lanata CF; Londoño JA; Lum LC; Rappaport R; Razmpour A; Walker RE; Gruber WC; Forrest BD
Vaccine; 2009 Sep; 27(40):5472-9. PubMed ID: 19616493
[TBL] [Abstract][Full Text] [Related]
16. Direct and indirect effectiveness of influenza vaccination delivered to children at school preceding an epidemic caused by 3 new influenza virus variants.
Glezen WP; Gaglani MJ; Kozinetz CA; Piedra PA
J Infect Dis; 2010 Dec; 202(11):1626-33. PubMed ID: 21028955
[TBL] [Abstract][Full Text] [Related]
17. Influenza control in the 21st century: Optimizing protection of older adults.
Monto AS; Ansaldi F; Aspinall R; McElhaney JE; Montaño LF; Nichol KL; Puig-Barberà J; Schmitt J; Stephenson I
Vaccine; 2009 Aug; 27(37):5043-53. PubMed ID: 19559118
[TBL] [Abstract][Full Text] [Related]
18. Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine--Marshfield, Wisconsin, 2007-08 influenza season.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Apr; 57(15):393-8. PubMed ID: 18418344
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials.
Rhorer J; Ambrose CS; Dickinson S; Hamilton H; Oleka NA; Malinoski FJ; Wittes J
Vaccine; 2009 Feb; 27(7):1101-10. PubMed ID: 19095024
[TBL] [Abstract][Full Text] [Related]
20. Duration of protection provided by live attenuated influenza vaccine in children.
Ambrose CS; Yi T; Walker RE; Connor EM
Pediatr Infect Dis J; 2008 Aug; 27(8):744-8. PubMed ID: 18600188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
